ISSN 1662-4009 (online)

ey0015.12-6 | Concepts revised | ESPEYB15

12.6 Monogenic Diabetes in Overweight and Obese Youth Diagnosed with Type 2 Diabetes: The TODAY Clinical Trial

JW Kleinberger , KC Copeland , RG Gandica , MW Haymond , LL Levitsky , B Linder , AR Shuldiner , S Tollefsen , NH White , TI Pollin , TODAY Study Group

To read the full abstract: Genetics in Medicine 2018;20:583-590Maturity Onset Diabetes of the Young (MODY) is a heterogeneous group of monogenic forms of diabetes characterized by pancreatic beta-cell dysfunction, with autosomal dominant inheritance. Fourteen distinct MODY genetic subtypes have been identified. A definitive diagnosis of MODY is very challenging because of similar or overlapping cl...

ey0020.10-3 | New Data on the Epidemiology of T2D in Children | ESPEYB20

10.3. The obesity paradox: Retinopathy, obesity, and circulating risk markers in youth with type 2 diabetes in the TODAY study

LL Levitsky , KL Drews , M Haymond , RA Glubitosi-Klug , LE Levitt Katz , M Mititelu , W Tamborlane , JB Tryggestad , RS Weinstock , RS TODAY Study Group

Brief summary: This study aimed to decipher the pathophysiology of the lower prevalence of diabetic retinopathy observed among youth with T2D who also have severe obesity. None of the several biomarkers assessed was found to be associated with the obesity paradox. The biomarkers included: inflammatory factors, acute phase reactants or cytokines (VEGF, hsCRP, ICAM-1, VCAM-1, homocysteine, adiponectin, E-selectin, MCP-1, TNF-α, IL-6, fibrinogen, and ApoB).<p class="abst...